Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

HONG KONG SAR – Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory ...

However, there is a way to protect yourself: vaccination. Last year, RSV vaccines reduced the risk of hospitalization or emergency visits by 75%, making them a powerful tool in preventing severe ...

US pharma giant Pfizer (NYSE: PFE) today announced that Jeffrey Legos will ... Dr Legos served as VP and global medicines development leader in oncology at the UK’s GSK (LSE: GSK). He also previously ...

Vaccines are available for the flu, COVID and RSV, and Russo and Omenka say vaccination could be crucial. "It is important for people to realize that these vaccines are critical for preventing ...

Add videos to your saved list and come back to them any time.

GSK has been the dominant player in the RSV vaccine market since Arexvy first gained approval in 2023, although Pfizer has made inroads into its market share. While initial launches for both ...

Shingrix, GSK’s shingles vaccine, saw a modest 1% increase in sales, while sales for its respiratory syncytial virus (RSV) vaccine Arexvy dropped by 51%. CEO Emma Walmsley acknowledged the ...